IAG Wealth Partners’s Avanos Medical AVNS Stock Holding History

IAG Wealth Partners’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$28	Hold	2	–	–	﹤0.01%	509
2025 Q4	$22	Hold	2	–	–	﹤0.01%	496
2025 Q3	$23	Hold	2	–	–	﹤0.01%	516
2025 Q2	$24	Hold	2	–	–	﹤0.01%	492
2025 Q1	$29	Hold	2	–	–	﹤0.01%	497
2024 Q4	$32	Hold	2	–	–	﹤0.01%	505
2024 Q3	$48	Hold	2	–	–	﹤0.01%	487
2024 Q2	$40	Hold	2	–	–	﹤0.01%	497
2024 Q1	$40	Hold	2	–	–	﹤0.01%	444
2023 Q4	$45	Hold	2	–	–	﹤0.01%	422
2023 Q3	$40	Hold	2	–	–	﹤0.01%	445
2023 Q2	$51	Hold	2	–	–	﹤0.01%	448
2023 Q1	$59	Hold	2	–	–	﹤0.01%	447
2022 Q4	$54	Hold	2	–	–	﹤0.01%	432
2022 Q3	$0	Hold	2	–	–	﹤0.01%	433
2022 Q2	$0	Hold	2	–	–	﹤0.01%	437
2022 Q1	$0	Hold	2	–	–	﹤0.01%	441
2021 Q4	$0	Hold	2	–	–	﹤0.01%	400
2021 Q3	$1K	Hold	2	–	–	﹤0.01%	373
2021 Q2	$1K	Hold	2	–	–	﹤0.01%	354
2021 Q1	$1K	Hold	2	–	–	﹤0.01%	348
2020 Q4	$1K	Hold	2	–	–	﹤0.01%	336
2020 Q3	$1K	Hold	2	–	–	﹤0.01%	333
2020 Q2	$1K	Hold	2	–	–	﹤0.01%	381
2020 Q1	$1K	Hold	2	–	–	﹤0.01%	366
2019 Q4	$1K	Buy	+2	New	+$72	﹤0.01%	406

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

IAG Wealth Partners's AVNS Position: Q1 2026 in Review

IAG Wealth Partners held its Avanos Medical (AVNS) position steady in Q1 2026 at 2 shares worth $28. The position accounts for ﹤0.01% of the portfolio, ranked #509.

IAG Wealth Partners first reported a position in AVNS in Q4 2019 and has held it in 26 quarters since. The position peaked at $1K in Q3 2021. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

IAG Wealth Partners held 2 shares of Avanos Medical worth $28 as of Q1 2026.
IAG Wealth Partners left its Avanos Medical share count unchanged in Q1 2026.
Avanos Medical made up ﹤0.01% of IAG Wealth Partners's portfolio in Q1 2026, its #509 holding.
IAG Wealth Partners first reported a position in Avanos Medical in Q4 2019 and has held it in 26 quarters since.
IAG Wealth Partners's Avanos Medical position peaked at $1K in Q3 2021.
257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on IAG Wealth Partners's 13F filing for Q1 2026, filed 29 Apr 2026.